Moderna CEO says Omicron COVID booster could be ready by March

Moderna President Stephen Hoge said Wednesday boosters of its COVID vaccine targeting the Omicron variant could be ready for U.S. authorization as early as March.

Moderna is also developing a multivalent vaccine targeting Omicron and three other COVID variants, although the shot will not be available for several more months, Forbes reported.

March is the earliest date an Omicron booster could be approved under current FDA guidelines, though the company can start manufacturing the vaccine during testing.

Hoge said he thinks existing vaccines “will be able to slow down, if not completely stop, the Omicron variant.”

Children’s Health Defense asks anyone who has experienced an adverse reaction, to any vaccine, to file a report following these three steps.